JP2012520665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520665A5 JP2012520665A5 JP2012500299A JP2012500299A JP2012520665A5 JP 2012520665 A5 JP2012520665 A5 JP 2012520665A5 JP 2012500299 A JP2012500299 A JP 2012500299A JP 2012500299 A JP2012500299 A JP 2012500299A JP 2012520665 A5 JP2012520665 A5 JP 2012520665A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- nucleic acid
- expression cassette
- peptide according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 244000045947 parasite Species 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000222722 Leishmania <genus> Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0951768A FR2943345B1 (fr) | 2009-03-19 | 2009-03-19 | Analogues de la temporine-sha et leurs utilisations |
| FR0951768 | 2009-03-19 | ||
| PCT/FR2010/050487 WO2010106293A1 (fr) | 2009-03-19 | 2010-03-18 | Analogues de la temporine-sha et leurs utilisations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012520665A JP2012520665A (ja) | 2012-09-10 |
| JP2012520665A5 true JP2012520665A5 (enExample) | 2013-04-25 |
| JP5713211B2 JP5713211B2 (ja) | 2015-05-07 |
Family
ID=41066385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012500299A Expired - Fee Related JP5713211B2 (ja) | 2009-03-19 | 2010-03-18 | テンポリン−ＳＨａ類縁体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9522942B2 (enExample) |
| EP (1) | EP2408806A1 (enExample) |
| JP (1) | JP5713211B2 (enExample) |
| BR (1) | BRPI1009585A2 (enExample) |
| CA (1) | CA2755472C (enExample) |
| FR (1) | FR2943345B1 (enExample) |
| WO (1) | WO2010106293A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3385343B2 (ja) | 1996-12-26 | 2003-03-10 | Ｎｔｎ株式会社 | トリポード型等速自在継手 |
| EP2853538A1 (en) | 2013-09-27 | 2015-04-01 | Université Pierre et Marie Curie (Paris 6) | Analogues of temporin-SHa and uses thereof |
| WO2015088344A1 (en) * | 2013-12-12 | 2015-06-18 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Antimicrobial peptide and uses thereof |
| CN106117333A (zh) * | 2016-07-06 | 2016-11-16 | 贵州师范大学 | 合江棘蛙皮肤抗菌肽及其编码序列的基因及原核表达 |
| US10550155B2 (en) * | 2018-03-27 | 2020-02-04 | Farzana Shaheen | Anticancer peptides |
| CA3221235A1 (en) | 2021-06-11 | 2022-12-15 | Ali Ladram | Short antimicrobial peptides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1194092A (en) * | 1991-02-06 | 1992-09-07 | Georgetown University | Receptor blocking peptides of fibroblast growth factor receptor |
| US5916872A (en) * | 1996-07-24 | 1999-06-29 | Intrabiotics Pharmaceuticals, Inc. | Cyclic peptides having broad spectrum antimicrobial activity |
-
2009
- 2009-03-19 FR FR0951768A patent/FR2943345B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-18 CA CA2755472A patent/CA2755472C/fr not_active Expired - Fee Related
- 2010-03-18 JP JP2012500299A patent/JP5713211B2/ja not_active Expired - Fee Related
- 2010-03-18 EP EP10716554A patent/EP2408806A1/fr not_active Withdrawn
- 2010-03-18 US US13/257,018 patent/US9522942B2/en not_active Expired - Fee Related
- 2010-03-18 WO PCT/FR2010/050487 patent/WO2010106293A1/fr not_active Ceased
- 2010-03-18 BR BRPI1009585A patent/BRPI1009585A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smith et al. | Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails | |
| JP2012520665A5 (enExample) | ||
| JP2012522037A5 (enExample) | ||
| JP2009526751A5 (enExample) | ||
| RS58980B1 (sr) | Peptidi i njihova upotreba | |
| JP2023510662A (ja) | 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用 | |
| CN114901291A (zh) | 抗菌有机硅烷 | |
| JP2009525284A (ja) | バイオフィルム関連感染を処置するためのガリウムの使用 | |
| EP3980373A1 (en) | Methods and compositions for generating nitric oxide and uses thereof | |
| JP2017526627A5 (enExample) | ||
| KR20150013280A (ko) | 박테리아 균막을 제거하기 위한 세아프로제의 용도 | |
| EP4138795A1 (en) | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 | |
| US20220280682A1 (en) | Antimicrobial compositions and articles comprising the same | |
| Salmani-Zarchi et al. | Antimicrobial feature of nanoparticles in the antibiotic resistance era: from mechanism to application | |
| Ma et al. | Bioinspired nanomaterials for the treatment of bacterial infections | |
| Singh | Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine | |
| JP2008508265A5 (enExample) | ||
| EP1609473A8 (en) | Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria | |
| DK180380B1 (en) | Combination therapy compositions for use in treating a bacterial biofilm in a subject and methods for killing, inhibiting or preventing the growth of a bacterial biofilm in vitro | |
| EP2766031B1 (en) | Antimicrobial peptides for treatment of infectious diseases | |
| BR112014007491A2 (pt) | sequências de aminoácidos para o controle de patógenos | |
| US11197824B2 (en) | Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus | |
| CN102940874A (zh) | 小分子多肽cw14在制备山羊抗菌药物中的应用 | |
| CN103285418A (zh) | 基于大面积烧伤创面用的新型生物抗菌敷料气雾剂 | |
| Singh et al. | Limiting Antibiotic-Resistant Bacteria Using Multifunctional Nanomaterials |